Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity

(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Gianfanco Calogiuri*, Alessandro Mandurino-Mirizzi, Claudio Parlangeli, Luigi Macchia, Caterina Foti and Michael P. Savage

Research output: Other contribution

Original languageEnglish
Number of pages11
DOIs
Publication statusPublished - 2019
Externally publishedYes

Keywords

  • Thienopyridines
  • hypersensitivity
  • ticlopidine
  • clopidogrel
  • prasugrel
  • ticagrelor desensitization
  • premedication.

Cite this

Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity : (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders). / Calogiuri*, Gianfanco ; Mandurino-Mirizzi, Alessandro ; Parlangeli, Claudio ; Macchia, Luigi ; Savage, Caterina Foti and Michael P. .

11 p. 2019, .

Research output: Other contribution

Calogiuri*, Gianfanco ; Mandurino-Mirizzi, Alessandro ; Parlangeli, Claudio ; Macchia, Luigi ; Savage, Caterina Foti and Michael P. . / Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity : (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders). 2019. 11 p.
@misc{2401bc6caf794211a9dc99cf6d09840f,
title = "Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity: (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)",
keywords = "Thienopyridines, hypersensitivity, ticlopidine, clopidogrel, prasugrel, ticagrelor desensitization, premedication.",
author = "Gianfanco Calogiuri* and Alessandro Mandurino-Mirizzi and Claudio Parlangeli and Luigi Macchia and Savage, {Caterina Foti and Michael P.}",
year = "2019",
doi = "10.2174/1871530318666180914121758",
language = "English",
isbn = "1871-5303/2212-3873",
type = "Other",

}

TY - GEN

T1 - Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity

T2 - (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

AU - Calogiuri, Gianfanco

AU - Mandurino-Mirizzi, Alessandro

AU - Parlangeli, Claudio

AU - Macchia, Luigi

AU - Savage, Caterina Foti and Michael P.

PY - 2019

Y1 - 2019

KW - Thienopyridines

KW - hypersensitivity

KW - ticlopidine

KW - clopidogrel

KW - prasugrel

KW - ticagrelor desensitization

KW - premedication.

U2 - 10.2174/1871530318666180914121758

DO - 10.2174/1871530318666180914121758

M3 - Other contribution

SN - 1871-5303/2212-3873

ER -